Tirzepatide

About this material

Tirzepatide is a 39-amino acid synthetic peptide analog produced using precision Solid-Phase Peptide Synthesis (SPPS) under controlled manufacturing parameters designed to ensure high sequence fidelity, molecular consistency, and reproducible batch quality. The peptide contains engineered sequence modifications and a covalently attached fatty diacid moiety, forming a chemically defined molecular architecture distinct from endogenous peptide sequences. Following synthesis, the material undergoes purification using High-Performance Liquid Chromatography (HPLC) before controlled lyophilization to maintain structural integrity, compositional uniformity, and analytical consistency throughout production.

Each manufacturing lot is evaluated through molecular identity confirmation, chromatographic purity assessment, peptide content verification, and physicochemical quality review prior to release. Standardized production controls are implemented to support reliable batch-to-batch reproducibility and consistent analytical performance. Every lot is accompanied by a batch-specific Certificate of Analysis (COA) documenting analytical verification, quality control review, and complete manufacturing traceability for scientific and analytical laboratory research.